Back to Journals » Journal of Experimental Pharmacology » Volume 13

Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab

Total article views   HTML views PDF downloads Totals
4,345 Dovepress* 3,905+ 438 4,343
PubMed Central* 440 146 586
Totals 4,345 584 4,929
*Since 31 May 2021
Total mentioned Facebook Delicious Reddit Twitter Others
12 0 0 0 6 6

View citations on PubMed Central and Google Scholar